Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO · Real-Time Price · USD
5.12
-0.08 (-1.54%)
At close: Feb 27, 2026, 4:00 PM EST
5.19
+0.07 (1.37%)
After-hours: Feb 27, 2026, 7:30 PM EST
Abeona Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Abeona Therapeutics stock have an average target of 18.2, with a low estimate of 15 and a high estimate of 20. The average target predicts an increase of 255.47% from the current stock price of 5.12.
Analyst Consensus: Strong Buy
* Price targets were last updated on Oct 13, 2025.
Analyst Ratings
The average analyst rating for Abeona Therapeutics stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +290.62% | Oct 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +290.62% | Aug 18, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $19 → $20 | Buy | Maintains | $19 → $20 | +290.62% | Aug 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +290.62% | Jul 16, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +290.62% | Jul 14, 2025 |
Financial Forecast
Revenue This Year
6.77M
Revenue Next Year
114.33M
from 6.77M
Increased by 1,589.77%
EPS This Year
1.26
from -1.55
EPS Next Year
-0.05
from 1.26
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 9.3M | 147.3M | ||||
| Avg | 6.8M | 114.3M | ||||
| Low | 4.1M | 78.2M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | 2,077.4% | ||||
| Avg | - | 1,589.8% | ||||
| Low | - | 1,056.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 1.49 | 0.21 | ||||
| Avg | 1.26 | -0.05 | ||||
| Low | 1.06 | -0.40 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | -83.3% | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.